Annual CFO
$748.50 M
+$79.00 M+11.80%
31 December 2023
Summary:
DexCom annual cash flow from operations is currently $748.50 million, with the most recent change of +$79.00 million (+11.80%) on 31 December 2023. During the last 3 years, it has risen by +$272.90 million (+57.38%). DXCM annual CFO is now at all-time high.DXCM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$199.50 M
-$79.90 M-28.60%
30 September 2024
Summary:
DexCom quarterly cash flow from operations is currently $199.50 million, with the most recent change of -$79.90 million (-28.60%) on 30 September 2024. Over the past year, it has dropped by -$69.70 million (-25.89%). DXCM quarterly CFO is now -31.96% below its all-time high of $293.20 million, reached on 30 September 2022.DXCM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$821.70 M
-$69.70 M-7.82%
30 September 2024
Summary:
DexCom TTM cash flow from operations is currently $821.70 million, with the most recent change of -$69.70 million (-7.82%) on 30 September 2024. Over the past year, it has increased by +$74.30 million (+9.94%). DXCM TTM CFO is now -7.82% below its all-time high of $891.40 million, reached on 30 June 2024.DXCM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DXCM Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.8% | -25.9% | +9.9% |
| 3 y3 years | +57.4% | -19.3% | +61.5% |
| 5 y5 years | +507.6% | +111.1% | +301.8% |
DXCM Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +69.2% | -32.0% | +181.0% | -7.8% | +85.7% |
| 5 y | 5 years | at high | +507.6% | -32.0% | >+9999.0% | -7.8% | +301.8% |
| alltime | all time | at high | +1811.4% | -32.0% | +1312.1% | -7.8% | +1843.1% |
DexCom Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $199.50 M(-28.6%) | $821.70 M(-7.8%) |
| June 2024 | - | $279.40 M(+33.6%) | $891.40 M(+11.1%) |
| Mar 2024 | - | $209.20 M(+56.6%) | $802.30 M(+7.2%) |
| Dec 2023 | $748.50 M(+11.8%) | $133.60 M(-50.4%) | $748.50 M(+0.1%) |
| Sept 2023 | - | $269.20 M(+41.5%) | $747.40 M(-3.1%) |
| June 2023 | - | $190.30 M(+22.5%) | $771.40 M(+2.3%) |
| Mar 2023 | - | $155.40 M(+17.3%) | $753.90 M(+12.6%) |
| Dec 2022 | $669.50 M(+51.3%) | $132.50 M(-54.8%) | $669.50 M(+4.2%) |
| Sept 2022 | - | $293.20 M(+69.7%) | $642.80 M(+7.7%) |
| June 2022 | - | $172.80 M(+143.4%) | $596.90 M(+22.9%) |
| Mar 2022 | - | $71.00 M(-32.9%) | $485.70 M(+9.8%) |
| Dec 2021 | $442.50 M(-7.0%) | $105.80 M(-57.2%) | $442.50 M(-13.0%) |
| Sept 2021 | - | $247.30 M(+301.5%) | $508.70 M(+24.4%) |
| June 2021 | - | $61.60 M(+121.6%) | $409.00 M(-18.4%) |
| Mar 2021 | - | $27.80 M(-83.8%) | $501.50 M(+5.4%) |
| Dec 2020 | $475.60 M(+51.2%) | $172.00 M(+16.5%) | $475.60 M(+6.3%) |
| Sept 2020 | - | $147.60 M(-4.2%) | $447.30 M(+13.5%) |
| June 2020 | - | $154.10 M(+8010.5%) | $394.20 M(+29.4%) |
| Mar 2020 | - | $1.90 M(-98.7%) | $304.60 M(-3.1%) |
| Dec 2019 | $314.50 M(+155.3%) | $143.70 M(+52.1%) | $314.50 M(+53.8%) |
| Sept 2019 | - | $94.50 M(+46.5%) | $204.50 M(+22.6%) |
| June 2019 | - | $64.50 M(+446.6%) | $166.80 M(+16.1%) |
| Mar 2019 | - | $11.80 M(-65.0%) | $143.70 M(+16.6%) |
| Dec 2018 | $123.20 M(+33.9%) | $33.70 M(-40.7%) | $123.20 M(-5.7%) |
| Sept 2018 | - | $56.80 M(+37.2%) | $130.70 M(+18.7%) |
| June 2018 | - | $41.40 M(-575.9%) | $110.10 M(+32.7%) |
| Mar 2018 | - | -$8.70 M(-121.1%) | $83.00 M(-9.8%) |
| Dec 2017 | $92.00 M(+63.7%) | $41.20 M(+13.8%) | $92.00 M(+43.5%) |
| Sept 2017 | - | $36.20 M(+153.1%) | $64.10 M(+25.9%) |
| June 2017 | - | $14.30 M(+4666.7%) | $50.90 M(-10.2%) |
| Mar 2017 | - | $300.00 K(-97.7%) | $56.70 M(+0.9%) |
| Dec 2016 | $56.20 M(+14.7%) | $13.30 M(-42.2%) | $56.20 M(+3.7%) |
| Sept 2016 | - | $23.00 M(+14.4%) | $54.20 M(+10.4%) |
| June 2016 | - | $20.10 M(<-9900.0%) | $49.10 M(+8.1%) |
| Mar 2016 | - | -$200.00 K(-101.8%) | $45.40 M(-7.3%) |
| Dec 2015 | $49.00 M(+107.6%) | $11.30 M(-36.9%) | $49.00 M(+6.3%) |
| Sept 2015 | - | $17.90 M(+9.1%) | $46.10 M(+16.4%) |
| June 2015 | - | $16.40 M(+382.4%) | $39.60 M(+34.7%) |
| Mar 2015 | - | $3.40 M(-59.5%) | $29.40 M(+24.6%) |
| Dec 2014 | $23.60 M | $8.40 M(-26.3%) | $23.60 M(+20.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $11.40 M(+83.9%) | $19.60 M(+100.0%) |
| June 2014 | - | $6.20 M(-358.3%) | $9.80 M(+117.8%) |
| Mar 2014 | - | -$2.40 M(-154.5%) | $4.50 M(+87.5%) |
| Dec 2013 | $2.40 M(-107.3%) | $4.40 M(+175.0%) | $2.40 M(-119.0%) |
| Sept 2013 | - | $1.60 M(+77.8%) | -$12.60 M(-37.6%) |
| June 2013 | - | $900.00 K(-120.0%) | -$20.20 M(-26.3%) |
| Mar 2013 | - | -$4.50 M(-57.5%) | -$27.40 M(-17.2%) |
| Dec 2012 | -$33.10 M(+10.0%) | -$10.60 M(+76.7%) | -$33.10 M(-2.8%) |
| Sept 2012 | - | -$6.00 M(-4.8%) | -$34.04 M(-2.1%) |
| June 2012 | - | -$6.30 M(-38.2%) | -$34.78 M(+12.2%) |
| Mar 2012 | - | -$10.20 M(-11.6%) | -$31.01 M(+3.0%) |
| Dec 2011 | -$30.10 M(-29.5%) | -$11.54 M(+71.3%) | -$30.10 M(-6.1%) |
| Sept 2011 | - | -$6.74 M(+166.9%) | -$32.04 M(-7.8%) |
| June 2011 | - | -$2.53 M(-72.8%) | -$34.77 M(-16.3%) |
| Mar 2011 | - | -$9.29 M(-31.1%) | -$41.55 M(-2.7%) |
| Dec 2010 | -$42.70 M(+8.4%) | -$13.49 M(+42.4%) | -$42.70 M(+11.2%) |
| Sept 2010 | - | -$9.47 M(+1.8%) | -$38.38 M(-0.9%) |
| June 2010 | - | -$9.30 M(-10.8%) | -$38.72 M(-4.3%) |
| Mar 2010 | - | -$10.44 M(+13.8%) | -$40.45 M(+2.7%) |
| Dec 2009 | -$39.39 M(+5.2%) | -$9.17 M(-6.5%) | -$39.39 M(+42.2%) |
| Sept 2009 | - | -$9.81 M(-11.1%) | -$27.69 M(-6.1%) |
| June 2009 | - | -$11.04 M(+17.8%) | -$29.50 M(-2.8%) |
| Mar 2009 | - | -$9.37 M(-471.0%) | -$30.36 M(-18.9%) |
| Dec 2008 | -$37.45 M(+12.8%) | $2.53 M(-121.7%) | -$37.45 M(-20.6%) |
| Sept 2008 | - | -$11.62 M(-2.4%) | -$47.14 M(+3.5%) |
| June 2008 | - | -$11.90 M(-27.7%) | -$45.53 M(+10.4%) |
| Mar 2008 | - | -$16.46 M(+129.7%) | -$41.26 M(+24.2%) |
| Dec 2007 | -$33.21 M(-24.1%) | -$7.16 M(-28.4%) | -$33.21 M(-7.8%) |
| Sept 2007 | - | -$10.01 M(+31.2%) | -$36.02 M(+3.5%) |
| June 2007 | - | -$7.63 M(-9.3%) | -$34.78 M(-14.7%) |
| Mar 2007 | - | -$8.41 M(-15.7%) | -$40.77 M(-6.8%) |
| Dec 2006 | -$43.73 M(+93.9%) | -$9.97 M(+13.7%) | -$43.73 M(+8.2%) |
| Sept 2006 | - | -$8.77 M(-35.6%) | -$40.42 M(+8.5%) |
| June 2006 | - | -$13.61 M(+19.7%) | -$37.25 M(+29.2%) |
| Mar 2006 | - | -$11.38 M(+70.8%) | -$28.82 M(+27.8%) |
| Dec 2005 | -$22.55 M(+81.5%) | -$6.66 M(+19.0%) | -$22.55 M(+41.9%) |
| Sept 2005 | - | -$5.60 M(+7.8%) | -$15.89 M(+54.4%) |
| June 2005 | - | -$5.19 M(+1.6%) | -$10.30 M(+101.6%) |
| Mar 2005 | - | -$5.11 M | -$5.11 M |
| Dec 2004 | -$12.43 M(+31.4%) | - | - |
| Dec 2003 | -$9.46 M | - | - |
FAQ
- What is DexCom annual cash flow from operations?
- What is the all time high annual CFO for DexCom?
- What is DexCom annual CFO year-on-year change?
- What is DexCom quarterly cash flow from operations?
- What is the all time high quarterly CFO for DexCom?
- What is DexCom quarterly CFO year-on-year change?
- What is DexCom TTM cash flow from operations?
- What is the all time high TTM CFO for DexCom?
- What is DexCom TTM CFO year-on-year change?
What is DexCom annual cash flow from operations?
The current annual CFO of DXCM is $748.50 M
What is the all time high annual CFO for DexCom?
DexCom all-time high annual cash flow from operations is $748.50 M
What is DexCom annual CFO year-on-year change?
Over the past year, DXCM annual cash flow from operations has changed by +$79.00 M (+11.80%)
What is DexCom quarterly cash flow from operations?
The current quarterly CFO of DXCM is $199.50 M
What is the all time high quarterly CFO for DexCom?
DexCom all-time high quarterly cash flow from operations is $293.20 M
What is DexCom quarterly CFO year-on-year change?
Over the past year, DXCM quarterly cash flow from operations has changed by -$69.70 M (-25.89%)
What is DexCom TTM cash flow from operations?
The current TTM CFO of DXCM is $821.70 M
What is the all time high TTM CFO for DexCom?
DexCom all-time high TTM cash flow from operations is $891.40 M
What is DexCom TTM CFO year-on-year change?
Over the past year, DXCM TTM cash flow from operations has changed by +$74.30 M (+9.94%)